Literature DB >> 6696817

Immunological detection of faecal occult blood in colorectal cancer.

M J Turunen, K Liewendahl, P Partanen, H Adlercreutz.   

Abstract

A new two-phase test kit for faecal occult blood combining a sensitive guaiac test (Fecatwin (S)ensitive) with an immunological test for human haemoglobin (FECA-EIA) was compared with three current guaiac tests (Fecatest, Fecatwin, Haemoccult) in 19 colorectal cancer patients and 11 controls on a restricted diet. A total of 43 48 h faecal samples (30 from cancer patients and 13 from controls) were collected for quantitative determination of faecal blood loss with the 51Cr method. Qualitative testing revealed that FECA-EIA was the most sensitive test, giving one (3%) false negative test result in the 30 tests on colorectal cancer patients and no false positives in the control subjects. It was also the only test that detected low-degree tumour bleeding. Fecatest and Fecatwin S were the most sensitive guaiac tests, giving 7 and 10% false negative test results, respectively, in the 30 colorectal cancer samples, whereas Haemoccult and Fecatwin gave 23% false negative test results. For screening purposes and in order to reduce costs it is suggested that only the positive test results of the very sensitive guaiac test (Fecatwin S) should be tested with the FECA-EIA test to eliminate false positive results. With this approach the diagnostic accuracy of the new two-phase test will be about twice as good as for the Haemoccult test.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696817      PMCID: PMC1976692          DOI: 10.1038/bjc.1984.26

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  Reliability of chemical tests for fecal occult blood in hospitalized patients.

Authors:  D W Morris; J R Hansell; J D Ostrow; C S Lee
Journal:  Am J Dig Dis       Date:  1976-10

2.  [Occult blood in the stool as a screening test for colo-rectal cancer and precancerous polyps. Field study on 815 adults].

Authors:  R Gnauck
Journal:  Z Gastroenterol       Date:  1974-06       Impact factor: 2.000

3.  Proctosigmoidoscopy and polypectomy in reducing the incidence of rectal cancer.

Authors:  V A Gilbertsen
Journal:  Cancer       Date:  1974-09       Impact factor: 6.860

4.  False positive and negative hemoccult reactions on a normal diet and effect of diet restriction.

Authors:  M L Bassett; K J Goulston
Journal:  Aust N Z J Med       Date:  1980-02

5.  Colorectal cancer: the challenge of early detection.

Authors:  M L Bassett; K J Goulston
Journal:  Med J Aust       Date:  1978-05-06       Impact factor: 7.738

6.  Evaluation of Fecatest, a new guaiac test for occult blood in feces.

Authors:  H Adlercreutz; K Liewendahl; P Virkola
Journal:  Clin Chem       Date:  1978-05       Impact factor: 8.327

7.  Colonoscopic biopsy and cytology in the diagnosis of colon cancer.

Authors:  S J Winawer; S D Leidner; S I Hajdu; P Sherlock
Journal:  Cancer       Date:  1978-12       Impact factor: 6.860

8.  Immunochemical detection of fecal occult blood--the fecal smear punch-disc test: a new non-invasive screening test for colorectal cancer.

Authors:  C L Songster; G H Barrows; D D Jarrett
Journal:  Cancer       Date:  1980-03-15       Impact factor: 6.860

9.  [Endoscopic diagnoses in patients with positive Hemoccult-test: critical consideration and negative Hemoccult-test (author's transl)].

Authors:  W Kruis; M Weinzierl; J Eisenberg
Journal:  Med Klin       Date:  1979-11-02

10.  Immunochemical detection of human blood in feces.

Authors:  G H Barrows; R M Burton; D D Jarrett; G G Russell; M D Alford; C L Songster
Journal:  Am J Clin Pathol       Date:  1978-03       Impact factor: 2.493

View more
  16 in total

1.  Generation of species-specific antihemoglobin antibodies by immunization with synthetic peptides of human hemoglobin.

Authors:  M Oshima; M Z Atassi
Journal:  J Protein Chem       Date:  1989-12

2.  [A new latex agglutination test for the immunologic detection of occult blood in stool].

Authors:  P Herzog; U König; K H Holtermüller
Journal:  Klin Wochenschr       Date:  1989-03-01

3.  Symposium: Screening for colorectal cancer.

Authors:  F Macrae; G Ekelund; B P Robra; R Gnauck; H Ribet; J Escourrou; J H Bond; N C Armitage; J B Simon
Journal:  Int J Colorectal Dis       Date:  1986-04       Impact factor: 2.571

4.  Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects.

Authors:  I Häkkinen; R Paasivuo; P Partanen
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

5.  Experimental detection of canine haemoglobin (occult blood) in canine faeces by reversed passive latex agglutination.

Authors:  T Jinbo; R Shinmura; T Shida; M Shimizu; M Honda; S Hayashi; K Iguchi; S Yamamoto
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

Review 6.  The pros and cons of fecal occult blood testing for colorectal neoplasms.

Authors:  J B Simon
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

7.  Clinical study of a new fecal occult blood test using a combination assay of hemoglobin and transferrin.

Authors:  H Miyoshi; K Uchida; R Matsuse; T Amatsu; C Shimamoto; I Hirata; S Ohshiba
Journal:  Gastroenterol Jpn       Date:  1991-04

8.  Immunochemical fecal occult blood test is inadequate for screening test of stomach cancer.

Authors:  H Nakama; B Zhang
Journal:  Dig Dis Sci       Date:  2000-11       Impact factor: 3.199

Review 9.  Screening for colorectal cancer: a critical review.

Authors:  J D Hardcastle; G Pye
Journal:  World J Surg       Date:  1989 Jan-Feb       Impact factor: 3.352

10.  Immunological detection of occult blood in faeces in colorectal cancer.

Authors:  D J St John; F A Macrae
Journal:  Br J Cancer       Date:  1984-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.